Search results for "pulmonary"

showing 10 items of 3030 documents

Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy

2015

Few data are available on the proportion of asthmatics achieving a good asthma control (according GINA guidelines) and on the level of airway inflammation during omalizumab treatment. The aim of this cross-sectional national observational study was to assess the level of control (according to GINA guidelines) achieved in a group of asthmatics on omalizumab treatment, and to characterize the factors that influence the lack of control. We studied 306 asthmatics under omalizumab treatment for a median of 32 months (range 4-120). The level of control according to GINA was good in 25.2%, partial in 47.1% and poor in 24.5% of patients (data were missing for the remaining 3.2%). Comparison between…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyExacerbationCross-sectional studyOmalizumabOmalizumabComorbiditySettore MED/10 - Malattie Dell'Apparato RespiratorioExhaled nitric oxide; Exacerbations; Comorbidities; Asthma; Omalizumab; ControlSeverity of Illness IndexComorbiditiesExacerbationsExhaled nitric oxideInternal medicineSeverity of illnessControlMedicineAnti-Asthmatic AgentHumansPharmacology (medical)Anti-Asthmatic AgentsInflammation MediatorAsthmaRespiratory Function TestAgedCross-Sectional Studiebusiness.industryBiochemistry (medical)ExacerbationMiddle Agedmedicine.diseaseComorbidityAsthmaRespiratory Function TestsCross-Sectional StudiesItalyExhaled nitric oxidePhysical therapyObservational studyAsthma; Comorbidities; Control; Exacerbations; Exhaled nitric oxide; Omalizumab; Adult; Aged; Anti-Asthmatic Agents; Asthma; Comorbidity; Cross-Sectional Studies; Female; Humans; Inflammation Mediators; Italy; Male; Middle Aged; Omalizumab; Respiratory Function Tests; Severity of Illness Index; Pulmonary and Respiratory Medicine; Biochemistry (medical); Pharmacology (medical)FemaleComorbiditieInflammation Mediatorsbusinessmedicine.drugHuman
researchProduct

Improvement of tricuspid regurgitation after pulmonary thromboendarterectomy

2002

For patients with chronic thromboembolic pulmonary hypertension who undergo pulmonary thromboendarterectomy (PTE) it has not yet been systematically investigated how operation affects the severity of tricuspid regurgitation (TR). This study sought (1) to evaluate the extent of TR reversibility after operation, (2) to identify potential predictors of the reversibility of TR, and (3) to investigate the influence of geometric and hemodynamic alterations on the extent of TR severity.Thirty-nine patients (55+/-12 years) undergoing PTE without tricuspid valve repair were investigated before and 13+/-8 days after operation by Doppler color flow mapping. Geometry of the tricuspid valve as well as r…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyHypertension Pulmonarymedicine.medical_treatmentHemodynamicsEndarterectomyRegurgitation (circulation)Pulmonary ArteryInternal medicinemedicineHumansAgedEndarterectomyTricuspid valvemedicine.diagnostic_testPulmonary thromboendarterectomybusiness.industryRespiratory diseaseMiddle Agedmedicine.diseasePulmonary hypertensionTricuspid Valve InsufficiencyEchocardiography Doppler Colormedicine.anatomical_structureCardiologyFemaleSurgeryCardiology and Cardiovascular MedicinebusinessElectrocardiographyThe Annals of Thoracic Surgery
researchProduct

Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer

2008

Limited information exists on the incidence of symptomatic venous thromboembolism (vTE) in patients undergoing chest surgery for lung cancer. Several factors increase the thromboembolic risk in patients undergoing surgery for lung cancer: the intrinsic procoagulant effect of cancer,extensive surgical intervention, dependent limb position in the operating room, and vessel injury consequent to the operation. Furthermore,these patients might be especially vulnerable to pulmonary embolism (PE) because of the loss of lung tissue and the presence of chronic obstructive pulmonary disease and cardiovascular diseases caused by smoking.t Older studies found a very high incidence of thromboembolic eve…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyLung Neoplasmsmedicine.medical_treatmentSeverity of Illness Indexvenous thromboembolism thoracotomySettore MED/15 - Malattie Del SangueCohort StudiesAge DistributionPostoperative ComplicationsRisk FactorsmedicineHumansMulticenter Studies as TopicThoracotomySex DistributionLung cancerPneumonectomyAgedNeoplasm StagingRetrospective StudiesAged 80 and overOntariobusiness.industryVascular diseaseIncidence (epidemiology)IncidenceRespiratory diseaseCancerAnticoagulantsRetrospective cohort studyVenous ThromboembolismMiddle Agedmedicine.diseasePrognosisSurvival AnalysisSurgeryVenous thrombosisItalyThoracotomyFemaleSurgerybusinessPulmonary EmbolismCardiology and Cardiovascular MedicineThe Journal of Thoracic and Cardiovascular Surgery
researchProduct

Airway inflammation in nonasthmatic amateur runners

2001

Elite athletes show a high prevalence of symptoms and signs of asthma, but no study has assessed the acute effects of endurance exercise on airway cells in nonasthmatic athletes. We measured exhaled nitric oxide (NO) and collected samples of induced sputum after 3% NaCl aerosol administration for 20 min in nonasthmatic middle-aged amateur runners after the Fourth Palermo International Marathon and 6–9 wk later (habitual training period) at baseline. After the marathon, exhaled NO ( n = 9 subjects) was higher [27 ± 9 parts/billion (ppb)] than at baseline (12 ± 4 ppb; P < 0.0005). Polymorphonuclear neutrophil (PMN) counts in induced sputum were much higher in runners (91.2 ± 3.6% of total…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyNeutrophilsPhysiologyMacrophage-1 AntigenPhysical exerciseNitric OxideRunningLeukocyte CountReference ValuesEndurance trainingPhysiology (medical)Internal medicinemedicineHumansL-SelectinBronchitisAsthmaBlood CellsbiologyAthletesbusiness.industryRespirationRespiratory diseaseSputumAirway inflammationCell BiologyMiddle Agedmedicine.diseasebiology.organism_classificationRespiratory Function TestsBloodCD18 AntigensPhysical therapyAirwaybusinesshuman activitiesAmateur
researchProduct

Airway remodelling assessed by sputum and high resolution computed tomography in asthma and COPD

2004

It is not known whether sputum elastase, metalloproteinase (MMP)-9 and tissue-inhibitor metalloproteinase (TIMP)-1 are related to structural changes of the airways, as assessed by high-resolution computed tomography (HRCT) scan. The relationships between these markers and the magnitude of structural changes of the airways in asthma and chronic obstructive pulmonary disease (COPD) were assessed. Induced sputum and HRCT scan were performed in 30 asthmatics (14 mild and 16 severe) and in 12 patients with COPD. A greater extent of HRCT scan abnormalities was found in COPD than in severe and mild asthmatics. HRCT scan abnormalities correlated with the degree of airway obstruction in COPD and in …

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyPathologyHigh-resolution computed tomographyairway inflammation imagingSettore MED/10 - Malattie Dell'Apparato RespiratorioGastroenterologyStatistics NonparametricPulmonary Disease Chronic ObstructiveInternal medicinemedicineHumansAirway RemodellingAgedAsthmaCOPDTissue Inhibitor of Metalloproteinase-1Pancreatic Elastasemedicine.diagnostic_testbusiness.industryElastaseRespiratory diseaseSputumMiddle Agedrespiratory systemAirway obstructionmedicine.diseaseAsthmaRespiratory Function Testsrespiratory tract diseasesMatrix Metalloproteinase 9SputumFemalemedicine.symptomTomography X-Ray Computedbusiness
researchProduct

Detection of lung cancer in exhaled breath with an electronic nose using support vector machine analysis

2017

Lung cancer is one of the most common malignancies and has a low 5-year survival rate. There are no cheap, simple and widely available screening methods for the early diagnostics of lung cancer. The aim of this study was to determine whether analysis of exhaled breath with an artificial olfactory sensor using support vector analysis can differentiate patients with lung cancer from healthy individuals and patients with other lung diseases, regardless of the stage of lung cancer and the most common comorbidities. Patients with histologically or cytologically verified lung cancer, healthy volunteers and patients with other lung diseases (e.g. chronic obstructive pulmonary disease (COPD), asthm…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyPathologyLung NeoplasmsSupport Vector MachinePulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansElectronic NoseLung cancerSurvival rateAgedNeoplasm StagingAsthmaCOPDLungbusiness.industryCancerMiddle Agedrespiratory systemmedicine.diseaseHealthy Volunteersrespiratory tract diseasesPneumoniamedicine.anatomical_structureBreath Tests030228 respiratory systemExhalationCase-Control Studies030220 oncology & carcinogenesisFemaleSample collectionbusinessJournal of Breath Research
researchProduct

Prospective evaluation of current asthma control using ACQ and ACT compared with GINA criteria

2011

Background The goal of asthma treatment is to achieve and maintain current best control and reduce future risk of exacerbations and long-term morbidity. Objective To prospectively compare current asthma control as defined by ACQ (asthma control questionnaire) and ACT (asthma control test) criteria with the GINA (Global Initiative for Asthma) classification in treated patients in a real-life setting. Methods In 150 adult patients (48% male, age 46.3 ± 14.4 years., forced expiratory volume in 1 second [FEV 1 ], 2.3 ± 0.9 L or 78.5 ± 21.8% pred.), asthma control was evaluated using the GINA classification as the "true" and ACQ-7, ACQ-5, and ACT as "predictor" criteria. The relationship between…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtySevere asthmaImmunologySensitivity and SpecificitySeverity of Illness IndexProspective evaluationPredictive Value of TestsForced Expiratory VolumeSurveys and QuestionnairesInternal medicineAsthma controlmedicineHumansImmunology and AllergyProspective StudiesAsthmaAdult patientsbusiness.industryMiddle Agedmedicine.diseasePredictive valueAsthmaBronchodilator Agentsrespiratory tract diseasesUncontrolled asthmaAsthma Control QuestionnairePhysical therapyFemalebusinessAnnals of Allergy, Asthma & Immunology
researchProduct

Analysis of risk factors for neurological dysfunction in patients with acute aortic dissection type A: data from the German Registry for Acute Aortic…

2012

OBJECTIVES: Acute aortic dissection type A (AADA) is associated with major adverse events, such as transient or persistent neurological dysfunction (ND), which may be patient-, disease- or surgery-related. There is a lack of consensus regarding risk factors for ND in AADA patients. The aim of this study was to analyse and identify risk factors for new postoperative ND after aortic repair for AADA. METHODS: Between July 2006 and June 2010, 2137 AADA patients were enrolled in the multi-centre, prospective German Registry of AADA (GERAADA). Perioperative data were prospectively gathered from 50 institutes in Austria, Switzerland and Germany, and multivariate logistic regression analysis was pe…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyTime FactorsOperative TimeAortic aneurysmPostoperative ComplicationsAneurysmRisk FactorsGermanymedicineHumansRegistriesSurvivorsEmergency TreatmentAgedRetrospective StudiesAortic dissectionAortic Aneurysm Thoracicbusiness.industryIncidencefungiRetrospective cohort studyGeneral MedicineOdds ratioPerioperativeMiddle Agedmedicine.diseaseSurgeryRadiographyAortic DissectionDissectionLogistic ModelsTreatment OutcomeCardiothoracic surgeryAustriaAcute DiseaseMultivariate AnalysisFemaleSurgeryNervous System DiseasesCardiology and Cardiovascular MedicinebusinessVascular Surgical ProceduresSwitzerlandFollow-Up StudiesEuropean Journal of Cardio-Thoracic Surgery
researchProduct

Outcome of patients with right heart thrombi: the Right Heart Thrombi European Registry

2015

Our aim was the assessment of the prognostic significance of right heart thrombi (RiHT) and their characteristics in pulmonary embolism in relation to established prognostic factors.138 patients (69 females) aged (mean±sd) 62±19 years with RiHT were included into a multicenter registry. A control group of 276 patients without RiHT was created by propensity scoring from a cohort of 963 contemporary patients. The primary end-point was 30-day pulmonary embolism-related mortality; the secondary end-point included 30-day all-cause mortality. In RiHT patients, pulmonary embolism mortality was higher in 31 patients with systolic blood pressure <90 mmHg than in 107 normotensives (42% versus 12%,…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyVentricular Dysfunction RightHemodynamicsBlood PressureKaplan-Meier Estimate030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineHumansMedicineRegistries030212 general & internal medicineAgedProportional Hazards ModelsAged 80 and overProportional hazards modelbusiness.industryHazard ratioHemodynamicsCase-control studyHeartThrombosisMiddle AgedPrognosismedicine.diseaseThrombosis3. Good healthPulmonary embolismSurgeryEuropeBlood pressureEchocardiographyCase-Control StudiesMultivariate AnalysisCohortCardiologyFemalePulmonary EmbolismbusinessEuropean Respiratory Journal
researchProduct

Measurement of Fractional Exhaled Nitric Oxide: Comparison of Three Different Analysers

2019

<b><i>Background:</i></b> Fractional exhaled nitric oxide (FeNO) is a surrogate marker for airway inflammation, supporting the diagnostic pathway and treatment decisions for asthma patients. <b><i>Objectives:</i></b> Aim of this study was to compare the new analyser Vivatmo pro (Bosch, BV) with NIOX VERO (Circassia, CN) and CLD (Ecomedics, EC). <b><i>Methods:</i></b> In 100 asthmatics (median 53 years [range 20–87], 62% female, 86% on inhaled corticosteroids [mean 1,300 μg beclomethasone dipropionate or equivalent], 35% treated with biologics) 2 FeNO measurements per device were performed. Additionally, the success rate…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyVital CapacityAnalyserClinical InvestigationsUrologyInhaled corticosteroidsNitric OxideYoung Adult03 medical and health sciences0302 clinical medicineForced Expiratory VolumeHumansMedicineAnti-Asthmatic Agents030212 general & internal medicineAgedAsthmaAged 80 and overbusiness.industryAirway inflammationMiddle Agedrespiratory systemmedicine.diseaseAsthmarespiratory tract diseasesBreath Tests030228 respiratory systemExhaled nitric oxideFemaleTreatment decision makingbusinessRespiration
researchProduct